Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Prestige Consumer Healthcare Inc.PBH · Entity 4350 | Senior VP Operations | May 11, 2026 | May 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Prestige Consumer Healthcare Inc.
Report date May 11, 2026 · Filed May 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 41,810 |
Reported balance
After 2026-05-11 transaction · row 1
1 source rowRow 1 · 2026-05-11 · Sale · Disposed 351 · Balance 41,810 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 06, 2019 Filed May 8, 2019 20:11 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantEmployee Stock Option (right to buy) · Derivative | 10,063 | $0.00 Strike: $30.32 | $0.00 |
DisclosureSEC source: 0001144204-19-024503 · tv521066_4.xml · derivative · entry 3 Zerillo Jeffrey · CIK 0001749501 · Senior VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,063 Underlying: Common Stock · 10,063 shares Expires 2029-05-06 F2 · derivative.exercise_date: The option vests in three annual installments as follows: 3,354 shares on each May 6, 2020, 2021 and 3,355 on May 6, 2022. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:11 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 3,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-024503 · tv521066_4.xml · nonDerivative · entry 1 Zerillo Jeffrey · CIK 0001749501 · Senior VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,986 F1 · shares: The restricted stock units vest in three annual installments as follows: 1,163 shares each on May 6, 2020, 2012 and 1,164 shares on May 6, 2022. Read SEC document |
| May 06, 2019 Filed May 23, 2019 20:05 UTC Amendment | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantEmployee Stock Option (right to buy) · Derivative | 10,063 | $0.00 Strike: $30.56 | $0.00 |
DisclosureSEC source: 0001144204-19-027966 · tv522370_4a.xml · derivative · entry 1 Zerillo Jeffrey · CIK 0001749501 · Senior VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,063 Underlying: Common Stock · 10,063 shares Expires 2029-05-06 F1 · derivative.exercise_price: This amendment is being filed to accurately reflect the exercise price of the options granted on May 6, 2019, which exercise price was inadvertently reported incorrectly in the original Form 4 filed on May 8, 2019. The correct exercise price is $30.56. F2 · derivative.exercise_date: The option vests in three annual installments as follows: 3,354 shares on each May 6, 2020, 2021 and 3,355 on May 6, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.